Lupin bags USFDA nod for Allopurinol Tablets Ruchika Sharma16 Dec 2023 1:30 PM ISTThe product will be manufactured at Lupin's Pithampur facility in India.
USFDA nod to Zydus Lifesciences cancer drug Cyclophosphamide Ruchika Sharma14 Dec 2023 3:24 PM ISTCyclophosphamide is a chemotherapy medication that slows the growth of cancer cells.
Medical Bulletin 13/December/2023 Roshni Dhar13 Dec 2023 3:00 PM ISTHere are the top medical news of the day:Study reveals insights into tacking diabetic kidney disease - with a side order of how anti-obesity drugs...
Cell therapy appears safe and effective for lymphoma in remission Roshni Dhar13 Dec 2023 9:15 AM ISTA study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T...
Cell therapy appears safe and effective for lymphoma in remission Dr. Kamal Kant Kohli12 Dec 2023 9:45 AM ISTA study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T...
Contrast agent use not necessary in PET/MRI scans in children with lymphoma: Study Medha Baranwal10 Dec 2023 9:15 PM ISTGermany: A recent study has provided a scientific baseline for choosing F-18 FDG-PET/MRI scans without the use of a contrast agent for imaging...
Gilead Kite declares positive trial results of T-cell Therapy Yescarta in Relapsed/Refractory Large B-cell Lymphoma Ruchika Sharma19 Sept 2023 1:30 PM ISTSanta Monica: Kite, a Gilead Company has announced results from the Phase 2 ALYCANTE study, led and sponsored by the French collaborative group...
CDSCO raises alert on fake Lymphoma drug Adcetris Injection manufactured by Takeda Pharma Dr. Divya Colin8 Sept 2023 6:00 PM ISTNew Delhi: Concerning falsified versions of Adcetris Injection (Brentuximab Vedotin) manufactured by Takeda Pharmaceutical, the Central Drugs Standard...
Roche gets European Commission nod for fixed duration Columvi for diffuse large B-cell lymphoma Ruchika Sharma11 July 2023 4:30 PM ISTColumvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.
MSN Lab Gets CDSCO Panel Nod to Manufacture, Market Nelarabine Injection Dr. Divya Colin24 Jun 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major MSN Laboratories has got the green signal from the Subject Expert Committee (SEC) functional...
Bristol Myers Squibb gets European Commission nod for CAR T Cell therapy Breyanzi for relapsed or refractory large B-cell lymphoma after one prior therapy Ruchika Sharma5 May 2023 2:30 PM ISTBreyanzi is a CD19-directed CAR T cell therapy with a 4-1BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells.
Roche blood cancer drug Columvi gets EMA panel recommendation for EU approval Ruchika Sharma28 April 2023 5:26 PM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
